Long-term exposure to air pollution may increase the risk of developing multiple sclerosis (MS), while short-term exposure may worsen disease activity and disability in people who already have the condition, according to a new study. “Long-term air pollution exposure was associated with higher MS risk, and short-term exposure with…
Discussion
Living with multiple sclerosis (MS) is often described in medical terms — lesions, relapses, progression curves, and other jargon — that don’t always register in my mind. But a diagnosis is also associated with grief, a quieter and oftentimes silent reality that doesn’t hit all at once, but…
Discussion
About 1 million people in the U.S. live with multiple sclerosis (MS). When I first heard that number, it felt like a cold statistic; today, it feels like a community. While MS has redrawn the boundaries of my physical world, it has failed to shrink the borders of…
A test that measures a specific set of proteins in cerebrospinal fluid (CSF) — the liquid that surrounds the brain and spinal cord — may help support the diagnosis of multiple sclerosis (MS), a new study shows. The approach could be particularly useful for people who lack a common…
Fenebrutinib, Genentech’s investigational BTK inhibitor, was found to significantly reduce relapse rates compared with the approved therapy Aubagio (teriflunomide) in two Phase 3 clinical trials involving people with relapsing forms of multiple sclerosis (MS). Positive top-line results from one of those trials, FENhance 2 (NCT04586023),…
Get regular updates to your inbox.
